台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    38.95
  • 漲跌
    ▲0.15
  • 漲幅
    +0.39%
  • 成交量
    74
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
生華科 (6492)籌碼相關-臺銀-民權 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/033537.54042.54547.550May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

臺銀-民權 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/3100.00238.1038.10-2161-1.23%
2025/03/282339.9600.0039.602315714.60%
2025/03/24241.9500.0041.8021491.34%
2025/03/18042.2500.0042.5001490.00%
2025/03/12244.2000.0044.1021471.36%
2025/03/0400.00543.3345.00-5152-3.27%
2025/03/0300.00744.6444.60-7153-4.57%
2025/02/21147.7500.0045.4011530.65%
2025/02/1800.00344.2544.25-3158-1.89%
2025/02/17644.80144.8044.7551623.08%
2025/01/211042.62141.9542.7093442.61%
2025/01/1500.00442.1342.15-4381-1.05%
2025/01/14343.0000.0042.6033820.78%
2025/01/13242.50342.3542.35-1384-0.26%
2025/01/06843.5100.0043.4083952.02%
2025/01/03142.8000.0042.3014020.25%
2025/01/02142.8500.0042.9014050.25%
2024/12/27145.0000.0044.2514210.24%
2024/12/2500.00242.6042.60-2441-0.45%
2024/12/13142.2500.0042.3515870.17%
2024/12/09143.5500.0043.8016000.17%
2024/12/06144.2500.0044.1516110.16%
2024/11/29145.5000.0046.0516390.16%
2024/11/28143.8500.0044.4516450.15%
2024/11/27744.3000.0044.2076551.07%
2024/11/221546.0000.0045.35156692.24%
2024/11/1400.00146.7546.45-1705-0.14%
2024/11/1300.00047.7547.2007190.00%
2024/11/1200.001347.2247.35-13726-1.79%
2024/11/0100.000.149.9050.00-0.1778-0.01%
2024/10/30350.7700.0050.5037770.39%
2024/10/29252.0500.0052.1027720.26%
2024/10/281454.09154.1052.60137561.72%
2024/10/2400.00249.6049.50-2623-0.32%
2024/10/23250.2000.0050.0026280.32%
2024/10/2100.00250.0049.90-2660-0.30%
2024/10/17152.3000.0050.5018500.12%
2024/10/16950.4600.0050.6099610.94%
2024/10/14449.75450.2050.4001,0570.00%
2024/09/26052.4000.0051.9001,0230.00%
2024/09/25153.90153.7053.8001,0180.00%
2024/09/19255.5000.0053.2029950.20%
2024/09/09147.30147.9548.2001,0340.00%
2024/09/02150.60450.1850.70-31,003-0.30%
2024/08/30351.5000.0051.3039990.30%
2024/08/28149.70349.6850.30-2981-0.20%
2024/08/27249.0000.0049.0029730.21%
2024/08/22049.80550.2049.80-5962-0.52%
2024/08/2100.00451.0050.60-4948-0.42%
2024/08/15248.7800.0049.6029170.22%
2024/08/14047.2000.0047.0509010.00%
2024/08/0900.00649.5048.15-6879-0.68%
2024/08/06950.00149.4049.0088410.95%
2024/08/05147.7000.0047.7018180.12%
2024/08/0200.00154.5053.00-1809-0.12%
2024/07/3000.000.755.0056.00-0.7794-0.08%
2024/07/2900.000.156.7056.90-0.1788-0.01%
2024/07/2300.00157.0054.10-1770-0.13%
2024/07/222.456.4700.0056.202.47520.31%
2024/07/19460.30359.2058.1017350.14%
2024/07/1824.462.5323.361.3862.201.16580.17%
2024/07/17858.04459.6358.9045430.74%
2024/07/16156.10256.2057.20-1427-0.23%
2024/07/1500.00652.0052.00-6337-1.78%
2024/07/09143.7000.0043.4013190.31%
2024/07/0300.00045.4045.0003080.00%
2024/07/02146.1500.0045.5013070.33%
2024/06/27747.86347.3047.1042961.35%
2024/06/26348.6010.147.5248.75-7.1288-2.46%
2024/06/241046.411045.7045.5002620.00%
2024/06/21546.70646.2845.20-1258-0.39%
2024/06/20048.8000.0047.6002500.01%
2024/06/19044.60444.1447.95-4224-1.77%
2024/06/1810.145.3600.0044.0010.12134.70%
2024/06/17345.10344.7045.3501870.00%
2024/06/06142.4000.0042.3511510.66%
2024/06/04142.3500.0041.8011530.65%
2024/05/14041.0000.0041.6001790.01%
2024/05/13041.0000.0041.0001800.00%
2024/05/09042.0000.0041.3501800.00%
2024/05/08041.9000.0041.6001800.00%
2024/04/23040.9500.0041.0001860.00%
2024/04/2200.00340.7040.65-3187-1.60%
2024/04/1900.00241.7040.70-2186-1.07%
2024/04/18042.5000.0041.9001820.00%
2024/04/0800.00344.3044.20-3191-1.57%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音
 
 
217小時28